Citations

Clear

1828 citation(s) found for "Su, Emily".

Chest CT Findings of Pneumocystis jirovecii Pneumonia in a Large Cohort of Patients Who Are Immunocompromised
Pulsipher, Aaron M. , Ham, Kealy, Vikram, Holenarasipur R. , Henry, Kyle J. , Thompson, Emily , Gotway, Michael B. , Ham, Kealy , Thompson, Emily R , Vikram, Holenarasipur R. , Gotway, Michael B , Henry, Kyle J , Pulsipher, Aaron M

Mayo Clinic

Radiology: Cardiothoracic Imaging | April 16, 2026 | Volume: 8 | Issue: 2 | Pages: No page available

10.1148/ryct.250361 | PMID 41989282 Get It

In a large, multicenter cohort of HIV and non–HIV immunocompromised patients with Pneumocystis jirovecii pneumonia, chest CT most commonly demonstrated diffusely distributed ground-glass opacity, with no imaging features distinguishing between immunocompromise etiology.
Intraoperative 3D Transesophageal Echocardiography for Early Detection of Pulmonary Vascular Complications in Lung Transplantation: A Case-Based Teaching Series
Fritz, Ashley Virginia , Saleem, Faiz , Allen, Wesley L. , Stephenson, Emily Paige, Martin, Archer Kilbourne , Saleem, Faiz R, Martin, Archer Kilbourne

Mayo Clinic

Seminars in Cardiothoracic and Vascular Anesthesia | April 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/10892532261442795 | PMID 41974431 Get It

Lung transplantation presents numerous intraoperative challenges, particularly related to pulmonary artery and vein anastomotic integrity and hemodynamic stability. We present 3 cases where intraoperative transesophageal echocardiography (TEE) provided real-time diagnostic insights that directly altered surgical decision-making. Case 1 highlights pulmonary vein flow acceleration initially concerning for ostial stenosis, ultimately diagnosed as external compression from a retractor. Case 2 demonstrates true right pulmonary vein stenosis requiring immediate revision. Case 3 illustrates severe right pulmonary artery narrowing, detected by TEE and corrected intraoperatively to prevent early graft dysfunction. These cases underscore the critical role of intraoperative TEE in detecting subtle anastomotic abnormalities, distinguishing functional from structural stenosis, and guiding timely surgical correction. Incorporating comprehensive 2D and 3D TEE evaluation into routine lung transplant protocols enhances diagnostic accuracy, reduces postoperative complications, and contributes to improved long-term allograft function. Intraoperative 3D TEE should be considered an essential imaging modality in cardiothoracic transplantation and an invaluable educational tool for perioperative teams.
T-cell activation and fibroblastic BMP4-Gremlin dysregulation indicate disease severity in acute myocarditis
Joachimbauer, Anna , Perez-Shibayama, Christian Ivan, Payne, Emily, Hanka, Isabella, Stadler, Roman, Papadopoulou, Iliana , Rickli, Hans , Maeder, Micha T, Zdanytė, Monika , Cooper, Leslie, Matter, Christian M. , Wilzeck, Verena C, Manka, Robert, Saguner, Ardan M, Ruschitzka, Frank, Schmidt, Dörthe, Gil-Cruz, Cristina Del Carmen, Perez‐Shibayama, Christian , Stadler, Roman, Maeder, Micha T. , Borst, Oliver , Cooper, Leslie, Flatz, Lukas , Wilzeck, Verena , Manka, Robert , Saguner, Ardan M. , Ruschitzka, Frank T. , Ludewig, Burkhard , Gil‐Cruz, Cristina

Mayo Clinic

No container title available | April 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.10.26350598 Get It

Abstract Background and Aims Acute myocarditis (AM) is a T cell-mediated myocardial disease with clinical manifestations ranging from mild chest pain to cardiogenic shock. Reliable biomarkers to stratify patients and guide therapy are currently lacking. In particular, the extent of the dysregulation of inflammatory pathways, and the impact on myocardial dysfunction, remain elusive. Methods Serum analyses were performed in prospectively recruited AM patients (n = 103) from two independent cohorts. Multimodal data integration combining profiling of cytokine and chemokine dysregulation with clinical biomarkers was used to define clinical phenotypes with distinct inflammatory signatures. Machine-learning and regression models were applied to determine biomarkers that indicate clinical severity. Results Immuno-proteomic profiling revealed conserved inflammatory patterns across AM cohorts, dominated by T cell-related cytokines and chemokines. In addition, AM patients showed dysregulation of fibroblast-derived cytokines, including hepatocyte growth factor (HGF), bone morphogenic protein 4 (BMP4) and the BMP4 inhibitors Gremlin-1 (GREM1) and Gremlin-2 (GREM2). Data integration and unsupervised clustering revealed two immuno-clinical phenotypes, linking T cell activation and fibroblast dysregulation to disease severity. Machine learning-based analysis identified CXCL10, GREM2 and LVEF as critical parameters for stratifying disease severity. Conclusions These findings highlight a systemic T cell activation signature as diagnostic hallmark of AM. In addition, dysregulation of fibroblast-derived tissue cytokines serves as an indicator for distinct immuno-clinical phenotypes in myocardial inflammatory disease. Thus, the clinically relevant link between T cell-driven immune activation, myocardial inflammation and fibroblast-driven remodelling provides a versatile set of parameters to identify severe manifestations of AM. Graphical Abstract Key Question: Are serological immune signatures linked to clinical severity in acute myocarditis and do they enable patient stratification? Key Findings: T cell- and fibroblast associated proteomic signatures indicate disease severity in acute myocarditis. Novel immuno-clinical phenotypes stratify patients according to distinct immune responses and clinical manifestations. CXCL10, GREM2 and LVEF are the most important parameters to identify immuno-clinical phenotypes. Take Home Message: CXCL10, GREM2 and LVEF emerge as key determinants for a severe immuno-clinical phenotype in acute myocarditis, highlighting the role of T cell-fibroblast interaction in the disease process and linking T cell activation, fibroblastic tissue remodelling and impaired cardiac function.
Methylene Blue Mouthwash for Oral Mucositis Pain in Cancer: An Open-Label, Non-Randomized Study
Karow, Jordan, Mackey, Regina M. , Olson, Emily, Wiste, Rachel, Siegel, Leslie R. , Strand, Jacob, Siegel, Leslie , Karow, Jordan C., Olson, Emily M. , Schroeder, Darrell R. , Lapid, Maria I.

Mayo Clinic

Journal of Pain & Palliative Care Pharmacotherapy | April 11, 2026 | Volume: 40 | Issue: 2 | Pages: 230-236

10.1080/15360288.2026.2655779 | PMID 41964386 Get It

Exploring Best Practices for Screening for Financial Toxicity in Patients With Sarcoma: A Single-Institution Study
Shenoy, Devika A , Sachs, Elizabeth , Yanez, Giussepe , Peairs, Emily M. , Cook, C. Edmisten, Brigman, Brian E. , Eward, William C., Sloan, Caroline E. , Hung, Anna , Sachs, Elizabeth , Yanez, Giussepe , Peairs, Emily, Visgauss, Julia D , Sloan, Caroline E , Eward, William C. , Visgauss, Julia D.

Mayo Clinic

JCO Oncology Practice | April 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/op-25-01192 | PMID 41955544 Get It

PURPOSE Approximately three quarters of patients with sarcoma report financial toxicity, defined as the psychosocial and economic burden of cancer care. The Comprehensive Score for Financial Toxicity (COST) is a screening questionnaire validated in patients with cancer. However, its use is not widespread in sarcoma care, likely in part due to its complexity. This study aimed to characterize financial toxicity in patients with sarcoma and evaluate whether shorter screening tools can identify high-risk patients. METHODS We conducted a survey and retrospective cohort study of patients treated for sarcoma at a large, academic sarcoma center in 2016-2024. Patients completed the COST questionnaire (11 graded questions, each scored on a five-point Likert scale from 0 to 4) and the shorter, four-question Worry about Affording Healthcare Scale (WAHS). We obtained clinical information from the electronic health record. We used descriptive statistics to summarize responses to COST, Pearson's correlation coefficient to assess the association between WAHS and COST, and stepwise Spearman correlations to evaluate whether an abbreviated (1-4 question) version of COST correlated highly with total COST score. RESULTS Among 205 participants, the mean COST score was 20/44 (standard deviation = 6; lower scores indicate greater financial toxicity). Respondents worried most about job loss (mean COST: 0.99) and family finances (mean COST: 1.11). WAHS was weakly correlated with COST (r = 0.47, P < .01). A four-item abbreviated COST tool was strongly correlated with the total COST (ρ = 0.906, P < .0001) and demonstrated high sensitivity (96%) and moderate specificity (75%). CONCLUSION An abbreviated four-item COST tool could act as a clinically feasible, accurate screening tool after external validation. Routine financial toxicity screening could facilitate timely detection and referral to essential financial navigation resources.
Pneumocystis jirovecii Pneumonia: Typical and Atypical CT Findings in a Large Cohort of Immunocompromised Patients with and without HIV
Pulsipher, Aaron M. , Ham, Kealy R., Vikram, Holenarasipur R. , Henry, Kyle, Thompson, Emily , Gotway, Michael B. , Henry, Kyle J. , Ham, Kealy , Henry, Kyle J , Thompson, Emily R , Vikram, Holenarasipur R. , Gotway, Michael B , Pulsipher, Aaron M

Mayo Clinic

Radiology: Cardiothoracic Imaging | April 9, 2026 | Volume: 8 | Issue: 2 | Pages: No page available

10.1148/ryct.250171 | PMID 41954473 Get It

This article describes the typical and atypical chest imaging appearances of Pneumocystis jirovecii pneumonia.
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies
Mohty, Razan , Narra, Ravi , Hunter, Cameron, Shallis, Rory M. , Jamy, Omer , Coltoff, Alexander , Othman, Tamer , Jonas, Brian A. , Patel, Anand , Foucar, Charles , Abdelsamia, Mahmoud , Palmisiano, Neil , Curran, Emily, Advani, Anjali, Atallah, E., Litzow, Mark R., Shallis, Rory M , Othman, Tamer , Jonas, Brian , Patel, Anand , Patel, Shyam A , Badar, Talha , Jamy, Omer , Mims, Alice S , Hunter, Cameron, Kota, Vamsi , DuVall, Adam , Patel, Shyam A. , Curran, Emily , Omer, Zulfa , Advani, Anjali S. , Atallah, Ehab , Litzow, Mark R. , Badar, Talha

Mayo Clinic

Leukemia & Lymphoma | April 9, 2026 | Volume: 67 | Issue: 7 | Pages: 1587-1594

10.1080/10428194.2026.2650679 | PMID 41954351 Get It

Trends in Blood Pressure Control During the COVID‐19 Pandemic: A Study of 17 US Health Systems in the National Patient‐Centered Clinical Research Network Blood Pressure Control Laboratory
Chamberlain, Alanna M. , Cooper‐DeHoff, Rhonda M. , Fontil, Valy , Park, Soo , Shaw, Kathryn M., Smith, Myra C., Carton, Thomas W. , O'Brien, Emily C, Modrow, Madelaine Faulkner , Wozniak, Gregory , Smith, Steven M., Kappelman, M. D., Ford, D. Patrick, Williams, David A. , VanWormer, Jeffrey J. , Cowell, Lindsay G., Taylor, Bradley W., Chrischilles, EA, Carton, Thomas , O'Brien, Emily , Faulkner Modrow, Madelaine , Rakotz, Michael , Smith, Steven M , Kappelman, Michael D , Ford, Daniel E , Williams, David A , Reynolds Geary, Carol , Litvin, Cara , VanWormer, Jeffrey J , Mosa, Abu Saleh Mohammad , Taylor, Bradley , Chrischilles, Elizabeth A , Pletcher, Mark J , Chamberlain, Alanna M , Cooper‐DeHoff, Rhonda M. , Fontil, Valy , Park, Soo , Shaw, Kathryn M., O’Brien, Emily C. , Rakotz, Michael , Kappelman, Michael D. , Geary, Carol , Taylor, Bradley , Pletcher, Mark J.

Mayo Clinic

Journal of the American Heart Association | April 7, 2026 | Volume: 15 | Issue: 8 | Pages: No page available

10.1161/jaha.125.045694 | PMID 41944158 Get It

Background Reductions in blood pressure (BP) control among patients with hypertension were observed early in the COVID‐19 pandemic. The degree to which BP control may have returned to prepandemic levels is unknown. Methods Individuals aged 18 to 85 years with hypertension from 17 health systems participating in the National Patient‐Centered Clinical Research Network were identified using electronic health record data collected as part of routine care. BP control (percentage of patients whose most recent BP measurement was <140/<90 mm Hg) was estimated in a series of 12‐month rolling measurement periods from 2017 through 2022 (January 1, 2017 through December 31, 2017; April 1, 2017 through March 31, 2018; … January 1, 2022 through December 31, 2022). Differences in average BP control between 2022 (January 1, 2022 through December 31, 2022) and 2019 (January 1, 2019 through December 31, 2019) were estimated overall (adjusted for age, sex, and race and ethnicity) and by race and ethnicity (adjusted for age and sex). Results Our sample included 1 193 314 persons with hypertension in 2019 (48.9% aged 65–85 years, 52.9% men, 66.2% non‐Hispanic White) and 1 499 418 individuals in 2022 (50.6% aged 65–85 years, 47.1% men, 62.7% non‐Hispanic White). The weighted average BP control dropped from 65.3% in 2019 to 61.8% in 2020 and then partially recovered to 62.6% in 2022 (adjusted mean difference, −2.6 percentage points [95% CI, −5.0 to −0.2]). Non‐Hispanic Asian individuals experienced the largest temporal drop in BP control, declining from 68.4% in 2019 to 63.9% in 2022. Conclusions BP control was disrupted during the COVID‐19 pandemic and had not fully rebounded to prepandemic levels by the end of 2022. Continued surveillance is needed to determine whether the decline in BP control will persist and will result in future adverse cardiovascular events.
Symptomatic and Urodynamic Outcomes After Spinal Cord De‐Tethering in Primary Tethered Cord Patients
Reeson, Emily A., Didde, Ryan , Lin, Chung Yon, Nelson, Ryan J. , Salevitz, Daniel , Tolan, Grace, Ronecker, Jennifer S., Grimsby, Gwen M. , Reeson, Emily A. , Lin, Chung‐Yon, Nelson, Ryan, Tolan, Grace C.

Mayo Clinic

Neurourology and Urodynamics | April 7, 2026 | Volume: 45 | Issue: 7 | Pages: 1328-1335

10.1002/nau.70288 | PMID 41943540 Get It

ABSTRACT Introduction It is controversial whether surgical correction of tethered spinal cord in non‐myelomeningocele tethered cord patients results in reversal versus stabilization of urologic (GU), gastrointestinal (GI), and musculoskeletal (MSK) symptoms. Objective To determine factors associated with clinical improvement in symptoms after spinal cord de‐tethering, and evaluate whether pre‐operative urodynamic testing predicts post‐operative clinical outcomes. Methods 213 non‐myelomeningocele children who underwent primary spinal cord de‐tethering at a quaternary children's hospital from 2012 to 2020 were retrospectively reviewed. Age at surgery, gender, and presence of GU symptoms, constipation, MSK symptoms, and urodynamic studies were collected. Pre‐operative symptoms and demographics were compared between patients with and without resolution of GU symptoms after surgery. Results Mean age at surgery was 5.36 years, 48% were female, and mean length of follow up was 1.8 years. Before surgery, 133/213 (62%) experienced a GU symptom. 105/213 (49%) patients were potty‐trained. Of 105 potty‐trained patients, 50 (48%) had daytime incontinence and 55 (52%) had nocturnal enuresis. Of 88 potty‐trained patients with urinary symptoms, 22 (25%) had resolution of and 59 (67%) had improvement following surgery. Of the 102 with constipation, 45 (44%) had improvement. Of the 116 with musculoskeletal symptoms, 60 (52%) had improvement. Patients with resolution of GU symptoms were younger (4.97 vs. 8 years, p = 0.0019). Patients with daytime urinary incontinence ( p = 0.0119) were less likely to have resolution of GU symptoms. There was no difference in urodynamic findings between patients with and without improvement or resolution of urologic symptoms. Conclusion Younger age at de‐tethering surgery is associated with improvement in genitourinary symptoms. Preoperative urodynamic studies may not be predictive of postoperative outcomes.
Addressing the Procedural Mismatch: Individualized Learning Plans to Align IM Residency Training with PCCM Fellowship Procedural Expectations
Spitzer, Carleen R. , Olson, Emily M. , Arnold, Jason, Santhosh, Lekshmi, Santhosh, Lekshmi , Krumm, Ilana Roberts

Mayo Clinic

ATS Scholar | April 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/atsscholar/aapag018 | PMID 41934627 Get It